The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a analysis of the IBIS 3 trial

Background: In the Italian Breast Cancer Intergroup Studies (IBIS) 3 phase III trial, we compared cyclophosphamide, methotrexate, 5-fluorouracil (CMF) alone to sequential epirubicin/CMF regimens in patients with rapidly proliferating early breast cancer (RPEBC). We performed a post hoc analysis in t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sara Bravaccini, Giuseppe Bronte, Emanuela Scarpi, Sara Ravaioli, Roberta Maltoni, Anita Mangia, Maria Maddalena Tumedei, Maurizio Puccetti, Patrizia Serra, Lorenzo Gianni, Laura Amaducci, Nicoletta Biglia, Valentina Bounous, Angelo Virgilio Paradiso, Rosella Silvestrini, Dino Amadori, Andrea Rocca
Format: Artigo
Langue:Inglês
Publié: SAGE Publishing 2020-02-01
Collection:Therapeutic Advances in Medical Oncology
Accès en ligne:https://doi.org/10.1177/1758835919888999
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires